Who is sponsoring DAPA-REMO?

DAPA-REMO is sponsored by Poznan University of Medical Sciences.

What condition does DAPA-REMO study?

DAPA-REMO studies Heart Failure.

What is the status of DAPA-REMO?

DAPA-REMO is currently UNKNOWN.

Last reviewed 2024-11-07 · How we verify

Effect of Flozin (dapagliflozin) Administration on Myocardial and Peripheral Vascular Remodeling (DAPA-REMO)

NCT06679179 UNKNOWN

The aim of this study is to assess the effect of treatment with flozin (dapagliflozin 10mg once a day) on haemodynamic parameters and myocardial and peripheral vascular remodeling in patients with NYHA class II-III heart failure.

Details

Lead sponsor	Poznan University of Medical Sciences
Status	UNKNOWN
Enrolment	50
Start date	Fri Mar 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Sat Feb 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Heart Failure

Countries

Poland